Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

News · May 26, 2021

ACC 2021: PRADA Long-Term Follow-Up Suggests Cardioprotection Unnecessary for Unselected Patients Undergoing Adjuvant Breast Cancer Treatment

At 2 years, no substantial benefit with either candesartan or metoprolol were noted

PracticeUpdate Editorial Team


Further Reading